On Invalid Date, Xortx Therapeutics (NASDAQ: XRTX) reported Q3 2023 earnings per share (EPS) of -$0.50, up 21.14% year over year. Total Xortx Therapeutics earnings for the quarter were -$987.68 thousand. In the same quarter last year, Xortx Therapeutics's earnings per share (EPS) was -$0.63.
As of Q2 2024, Xortx Therapeutics's earnings has grown year over year. Xortx Therapeutics's earnings in the past year totalled -$5.63 million.
What is XRTX's earnings date?
Xortx Therapeutics's earnings date is Invalid Date. Add XRTX to your watchlist to be reminded of XRTX's next earnings announcement.
What was XRTX's revenue last quarter?
On Invalid Date, Xortx Therapeutics (NASDAQ: XRTX) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Xortx Therapeutics's revenue was $0.00.
What was XRTX's revenue growth in the past year?
As of Q2 2024, Xortx Therapeutics's revenue has grown null year over year. Xortx Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.